4
Changes in Ownership
Adaptimmune Therapeutics PLC Filed Acc 0001104659-19-002165
Chief Operating Officer sold 2,271 shares at $5.37 ($12,194)
From the SEC's structured data for this filing
Adaptimmune Therapeutics PLC Filed Acc 0001104659-19-002165
Chief Operating Officer sold 2,271 shares at $5.37 ($12,194)
From the SEC's structured data for this filing
Connection lost
Reconnecting…
Cite Filings isn't responding
Reconnecting…